title: Cholesterol lowering and cerebrospinal fluid neurotransmitters: increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin administration to healthy male volunteers.
authors.affiliation: Department of Medicine, Huddinge University Hospital, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Eriksson
authors.forename: T
authors.initials: T
authors.lastname: Eklundh
authors.forename: S
authors.initials: S
authors.lastname: Sjöberg
authors.forename: B
authors.initials: B
authors.lastname: Angelin
authors.forename: C
authors.initials: C
authors.lastname: Nordin
mesh_terms: D000328:Adult; D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D002784:Cholesterol / Q000378:metabolism*; D006801:Humans; D008148:Lovastatin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D008297:Male; D018377:Neurotransmitter Agents / Q000134:cerebrospinal fluid*; D012016:Reference Values; D019821:Simvastatin; D013758:Tetragastrin / Q000378:metabolism*
chemical_list: D000924:Anticholesteremic Agents; D018377:Neurotransmitter Agents; D013758:Tetragastrin; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin